%0 Journal Article
%T Intralesional epidermal growth factor treatment on diabetic foot ulcers: one centre experience
%A Ayd£¿n £¿ifci
%J -
%D 2018
%X Introduction: The intralesional injection of recombinant human epidermal growth factor (EGF-IL) is a new approach for reducing amputations. In this study we aimed to show efficacy of EGF-IL with cases. Material and Method: EGF-IL 75 ¦Ìg application to 8 diabetic foot ulcers (6 males, 2 females; mean age: 60.3¡À9.3 years) was evaluated. Patients had history of prior standard treatments. Results: In all eight patients¡¯ completely healing was observed diabetic foot ulcers after the intralesional EGF treatment. Conclusion: In our experience our patients¡¯ wounds wish priorly have healing problems, improved with intralesional EGF. This treatment is expensive and caused of some allergic reactions. Relation with malignancies are not known for long-term
%K Diyabet
%K ayak ¨¹lseri
%K EGF
%K yara iyile£¿mesi
%U http://dergipark.org.tr/jhsm/issue/36933/397000